You will be redirected to the related website.
This information helps us optimize our content and make surfing on our site more convenient for you. In some cases, cookies are also used to make specific information about our products available on websites of other providers. This is why we also work with external service companies which use the information obtained from cookies exclusively for this purpose.
The information obtained from cookies is not used for any further purpose.
You can adjust the settings on your browser so that you are notified whenever a server wants to send you a cookie. You can accept or reject cookies; you can also completely block them. Further information is available in the help function of your browser.
In light of the discussion about the use of Analysetools and complete IP addresses, we wish to state that this website works with Google Analytics and the "_anonymizeIp()" function; consequently, it only processes partial IP addresses so as to rule out identifying information.
You can refuse the use of Google Analytics by clicking on the following link. An opt-out cookie will be set on the computer, which prevents the future collection of your data when visiting this website: Disable Google Analytics.*
Respiratory tract infections usually start with a common cold, typically accompanied by a sore throat and runny nose, and may develop into bronchitis within three to four days of starting a cold.
During the winter months, acute bronchitis is responsible for roughly every second medical consultation. More than 90 percent of such infections are caused by viruses and do not require antibiotic treatment. Despite the fact that nine out of ten respiratory tract infections are caused by viruses, the majority of children with acute bronchitis are still given antibiotic treatment. In fact, there is no scientific evidence that antibiotics help at all in cases of viral infections.
Primary treatment therefore aims to relieve symptoms, to shorten the duration of illness and to speed-up return to school or work. This is where the well-documented special extract from Pelargonium sidoides root (EPs® 7630) actually can help, as has been shown in clinical studies. The root extract also has a very good safety profile and is recommended by experts as an effective and well-tolerated treatment, particularly in children and adolescents. This has also been confirmed by an updated guideline for “cough” from German general practitioners and family physicians. For small children and preschool children too, EPs® 7630 offers an efficacious and safe option for the treatment of acute respiratory tract infections. The interview with Prof. Kamin, head of the department for Paediatrics in Hamm, Germany, provides more detailed information.